Biosecurity dilemmas : dreaded diseases, ethical responses, and the health of nations

Biosecurity Dilemmas Examines Conflicting Values And Interests In The Practice Of Biosecurity, The Safeguarding Of Populations Against Infectious Diseases Through Security Policies. Biosecurity Encompasses Both The Natural Occurrence Of Deadly Disease Outbreaks And The Deliberate Or Accidental Release Of Biological Weapons. Enemark Focuses On Six Dreaded Diseases That Are Given High-priority By Governments And International Organizations For Research, Regulation, Surveillance, And Rapid Response: Pandemic Influenza, Drug-resistant Tuberculosis, Smallpox, Ebola Virus, Bubonic Plague, And Anthrax. The Book Is Organized Around Four Ethical Dilemmas That Arise When Fear Causes These Diseases To Be Framed In Terms Of National Or International Security: Protect Or Proliferate, Secure Or Stifle, Remedy Or Overkill, And Attention Or Neglect. For Instance, Will Prioritizing Research Into Defending Against A Rare Event Such As A Bioterrorist Attack Divert Funds Away From Research Into Commonly Occurring Diseases? Or Will Securitizing A Particular Disease Actually Stifle Research Progress Due To Security Classification Measures? Enemark Provides A Comprehensive Analysis Of The Ethics Of Securitizing Disease And Explores Ideas And Policy Recommendations About Biological Arms Control, Global Health Security, And Public Health Ethics. Protect Or Proliferate. Biodefense And The Security Dilemma ; Vertical Proliferation And Threats From Within -- Secure Or Stifle. Laboratory Biosecurity ; Export And Publication Controls -- Remedy Or Overkill. Social Distancing And National Security ; Border Security And Transnational Contagion -- Attention Or Neglect. The Agenda Of Global Health Security ; Public Health And Biodefense Priorities. Christian Enemark. Includes Bibliographical References (pages 187-194) And Index. "Biosecurity Dilemmas examines conflicting values and interests in the practice of "biosecurity," the safeguarding of populations against infectious diseases through security policies. Biosecurity encompasses both the natural occurrence of deadly disease outbreaks and the deliberate or accidental release of biological weapons. Enemark focuses on six dreaded diseases that are given high-priority by governments and international organizations for research, regulation, surveillance, and rapid response: pandemic influenza, drug-resistant tuberculosis, smallpox, Ebola virus, bubonic plague, and anthrax. The book is organized around four ethical dilemmas that arise when fear causes these diseases to be framed in terms of national or international security: protect or proliferate, secure or stifle, remedy or overkill, and attention or neglect. For instance, will prioritizing research into defending against a rare event such as a bioterrorist attack divert funds away from research into commonly occurring diseases? Or will securitizing a particular disease actually stifle research progress due to security classification measures? Enemark provides a comprehensive analysis of the ethics of securitizing disease and explores ideas and policy recommendations about biological arms control, global health security, and public health ethics."--Page 4 de la couverture

Biosecurity Dilemmas examines conflicting values and interests in the practice of “biosecurity,” the safeguarding of populations against infectious diseases through security policies. Biosecurity encompasses both the natural occurrence of deadly disease outbreaks and the use of biological weapons. Christian Enemark focuses on six dreaded diseases that governments and international organizations give high priority for research, regulation, surveillance, and rapid response: pandemic influenza, drug-resistant tuberculosis, smallpox, Ebola, plague, and anthrax. The book is organized around four ethical dilemmas that arise when fear causes these diseases to be framed in terms of national or international security: protect or proliferate, secure or stifle, remedy or overkill, and attention or neglect. For instance, will prioritizing research into defending against a rare event such as a bioterrorist attack divert funds away from research into commonly occurring diseases? Or will securitizing a particular disease actually stifle research progress owing to security classification measures? Enemark provides a comprehensive analysis of the ethics of securitizing disease and explores ideas and policy recommendations about biological arms control, global health security, and public health ethics.

Cover Contents List of Tables Acknowledgments Abbreviations Introduction PART I. PROTECT OR PROLIFERATE 1. Biodefense and the Security Dilemma 2. Vertical Proliferation and Threats from Within PART II. SECURE OR STIFLE 3. Laboratory Biosecurity 4. Export and Publication Controls PART III. REMEDY OR OVERKILL 5. Social Distancing and National Security 6. Border Security and Transnational Contagion PART IV. ATTENTION OR NEGLECT 7. The Agenda of Global Health Security 8. Public Health and Biodefense Priorities Conclusion Selected Bibliography Index A B C D E F G H I J K L M N O P Q R S T U V W Z About the Author Biosecurity encompasses both the natural occurrence of deadly disease outbreaks and the use of biological weapons. This book examines conflicting values and interests in the practice of "biosecurity," the safeguarding of populations against infectious diseases through security policies.